机构:[1]Chinese Peoples Liberat Army Gen Hosp, Med Big Data Res Ctr, 28 Fuxing Rd, Beijing 100853, Peoples R China[2]Chinese Peoples Liberat Army Gen Hosp, Beijing Key Lab Precis Med Chron Heart Failure, Beijing, Peoples R China[3]Yale Univ, Howard Hughes Med Inst, Dept Genet, Sch Med, New Haven, CT 06510 USA[4]Westlake Univ, Sch Life Sci, Key Lab Growth Regulat & Translat Res Zhejiang Pro, Hangzhou 310024, Peoples R China[5]Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Med Ctr 4, Beijing 100037, Peoples R China[6]Chinese Peoples Liberat Army Gen Hosp, Dept Ultrasound Diag, Med Ctr 1, Beijing 100853, Peoples R China[7]Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Med Ctr 1, Beijing 100853, Peoples R China[8]Beijing Tongren Hosp, Dept Cardiol, Beijing 100176, Peoples R China临床科室心血管中心首都医科大学附属北京同仁医院首都医科大学附属同仁医院[9]Chinese PLA 923 Hosp, Dept Ultrasound, Nanning 530021, Peoples R China[10]Columbia Univ, Div Cardiol, New York, NY 10027 USA
Echocardiography is the first-line diagnostic technique for heart diseases. Although artificial intelligence techniques have made great improvements in the analysis of echocardiography, the major limitations remain to be the built neural networks are normally adapted to a few diseases and specific equipment. Here, we present an end-to-end deep learning framework named AIEchoDx that differentiates four common cardiovascular diseases (Atrial Septal Defect, Dilated Cardiomyopathy, Hypertrophic Cardiomyopathy, prior Myocardial Infarction) from normal subjects with performance comparable to that of consensus of three senior cardiologists in AUCs (99.50% vs 99.26%, 98.75% vs 92.75%, 99.57% vs 97.21%, 98.52% vs 84.20%, and 98.70% vs 89.41%), respectively. Meanwhile, AIEchoDx accurately recognizes critical lesion regions of interest along with each disease by visualizing the decision-making process. Furthermore, our analysis indicates that heterogeneous diseases, like dilated cardiomyopathy, could be classified into two phenogroups with distinct clinical characteristics. Finally, AIEchoDx performs efficiently as an anomaly detection tool when applying handheld device-produced videos. Together, AIEchoDx provides a potential diagnostic assistant tool in either cart-based echocardiography equipment or handheld echocardiography device for primary and point-of-care medical personnel with high diagnostic performance, and the application of lesion region identification and heterogeneous disease phenogrouping, which may broaden the application of artificial intelligence in echocardiography.
基金:
Ministry of Science and Technology of the People's Republic of China [2021ZD0140406]; Ministry of Industry and Information Technology of the People's Republic of China [2020-0103-3-1]; National Natural Science Foundation of China [31701155]
第一作者机构:[1]Chinese Peoples Liberat Army Gen Hosp, Med Big Data Res Ctr, 28 Fuxing Rd, Beijing 100853, Peoples R China[2]Chinese Peoples Liberat Army Gen Hosp, Beijing Key Lab Precis Med Chron Heart Failure, Beijing, Peoples R China
共同第一作者:
通讯作者:
通讯机构:[1]Chinese Peoples Liberat Army Gen Hosp, Med Big Data Res Ctr, 28 Fuxing Rd, Beijing 100853, Peoples R China[2]Chinese Peoples Liberat Army Gen Hosp, Beijing Key Lab Precis Med Chron Heart Failure, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Liu Bohan,Chang Hao,Yang Dong,et al.A deep learning framework assisted echocardiography with diagnosis, lesion localization, phenogrouping heterogeneous disease, and anomaly detection[J].SCIENTIFIC REPORTS.2023,13(1):doi:10.1038/s41598-022-27211-w.
APA:
Liu, Bohan,Chang, Hao,Yang, Dong,Yang, Feifei,Wang, Qiushuang...&He, Kunlun.(2023).A deep learning framework assisted echocardiography with diagnosis, lesion localization, phenogrouping heterogeneous disease, and anomaly detection.SCIENTIFIC REPORTS,13,(1)
MLA:
Liu, Bohan,et al."A deep learning framework assisted echocardiography with diagnosis, lesion localization, phenogrouping heterogeneous disease, and anomaly detection".SCIENTIFIC REPORTS 13..1(2023)